Daicel Chiral Technologies is a global leader in enantioselective chromatography, serving pharmaceutical and other life science industries. They offer a broad array of chiral chromatography products, including chiral stationary phases (CSPs) and analytical and preparative chiral columns for the separation of racemic mixtures into single enantiomers. The company also provides analytical method development and custom separation services.

Daicel Chiral Technologies

As a subsidiary of Daicel Corporation, Chiral Technologies, Inc. d/b/a Daicel Chiral Technologies, is a global market leader in chromatography products for the life sciences market, offering an extensive portfolio of both achiral and chiral stationary phases. Scientists in the pharmaceutical, agricultural and food industries, universities and government agencies rely on our expertise to analyze and purify molecules in research and development departments, QC laboratories and manufacturing.

Happy New Year! Be sure to check out our latest application note. 
https://lnkd.in/ei_ExUuS

Be sure to check out our latest application note!
https://lnkd.in/dPy5dAnY

Daicel has launched a chromatography column box and holder that is both fully recyclable and durable ensuring robust storage for the column. This eco-friendly packaging aligns with Daicel's commitment to sustainability, and we're eager to continue developing products that offer solutions for a clean environment.

Separate yourself from your desk and join us at EAS 2023. Don’t miss our expert presentations on Monday and Wednesday. 

Poster: Polysaccharide-based Chiral Stationary Phases for the Separation of Atropisomers 
Date: November 13   Time: 12:30 pm - 1:25 pm 
Presenter: John Ferraro 
 
Technical talk: New Technologies and Techniques for the Separation of Oligonucleotides and Polypeptides  
Date: November 15   Time: 1:30 pm   Room 111A 
Presenter: Weston Umstead, Ph.D. 
Session: Applications of Analytical Chemistry in Proteomic Research 
 
 #EAS2023, #easternanalyticalsymposium, #analytical, #chiral, #atropisomers, #oligonucleotides, #polypeptides

Check out our latest application note! 
https://lnkd.in/dVnk9Nkb

Join us at this year’s EAS Conference - November 13-15, at the Crown Plaza Princeton Conference Center in New Jersey. 

Don’t miss out on the opportunity to connect with our experts and to join our tech talk and poster session. You’ll find us at Booth W7.

Technical talk: “New Technologies and Techniques for the Separation of Oligonucleotides and Polypeptides” by Weston Umstead
Poster: Polysaccharide-based Chiral Stationary Phases for the Separation of Atropisomers
#EAS2023, #easternanalyticalsymposium. #chemistry, #analytical, #chiral, #science

Check out the latest work from Prof. Michael Lammerhofer and team on the analysis of chiral proteinogenic amino acids using Daicel’s CHIRALPAK® QN-AX. 
https://lnkd.in/d7kfwiDj
#Daicel Chiral Technologies, #CHIRALPAK QN/AX, #proteinogenic amino acids

Daicel Corporation establishes Daicel Medical Ltd., to accelerate the expansion of their medical-related life sciences business.
https://lnkd.in/dmPrTngP

Daicel Group continues to grow their presence in the life sciences arena. Read the latest news on their collaboration with Pharmajet. https://lnkd.in/gxFHVTkR

Metric
Company Name	Daicel Chiral Technologies
Symbol
MSH ID	COM:CHIRALTECH
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Life Sciences
Country	US
Stage
Employee Count	118
Website	chiraltech.com
LinkedIn	daicel-chiral-technologies
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	2.27K
Web Traffic Growth	2.26
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CHIRALTECH

Daicel Chiral Technologies

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue